相关期刊:《World Journal of Gastroenterology》《International Journal of Ophthalmology(English edition)》《Hepatobiliary & Pancreatic Diseases International》《Chinese Medical Journal》更多>>
This work was supported by the Natural Science Foundation of China(Nos.81330071,31390433 and 81922028);the Fundamental Research Funds for the Central Universities(WK9110000168);the Youth Innovation Promotion Association of Chinese Academy of Sciences(No.2019442).
Patients with chronic hepatitis B(CHB)undergoing interferon(IFN)-α-based therapies often exhibit a poor HBeAg serological response.Thus,there is an unmet need for new therapies aimed at CHB.This study comprised two c...
AIM: To establish the efficacy and safety of bimatoprost 0.03% monotherapy in glaucoma and ocular hypertension (OHT) patients with inadequate intraocular pressure (lOP) on current therapy. METHODS: Pre- and pos...
Hepatitis B virus(HBV) infection is still a serious worldwide problem, and vaccination is the most effective strategy for primary prevention of the infection. Although universal vaccination may be required for total e...
Cardiac resynchronization therapy (CRT) is a major breakthrough in therapy for patients with advanced congestive heart failure, however, a number of key clinical research questions remain, perhaps most importantly t...
Background Cardiac resynchronization therapy (CRT) is a major breakthrough in therapy for advanced heart failure patients; however, a number of key clinical research questions remain, perhaps most importantly the is...
Supported by Sofia-Kovalevskaja Award of the Alexander von Humboldt Foundation (JL Schultze), No. 37888309, Koeln Fortune (MR Weihrauch)
AIM: To evaluate, whether humoral hepatitis-B-vaccine non-responders also fail to mount a T cell response and to compare these results to normal vaccinees. METHODS: Fourty-seven health care employees were enrolled in ...
BACKGROUND: Treatment of chronic hepatitis B (CHB) alone with interferon or lamivudine alone or in combination is effective in only a small proportion of patients. Treatment of patients in whom antiviral therapy fails...
Objective With the same times of injection to compare low-dose intradermal regimen with routine-dose intramuscular inoculation in revaccination of non-responders to hepatitis B vaccine. Methods 40 healthy non-responde...
AIM: To evaluate the efficacy of amantadine plus interferonalpha and ribavirin in non-responder patients with chronic hepatitis C.METHODS: Twenty-six non-responder patients received the regimen of IFN-α-2a at a dose ...
AIM: To investigate the safety and efficacy of long-term combination therapy with alpha interferon and lamivudine in non-responsive patients with anti-HBe-positive chronic hepatitis B.METHODS: 34 patients received com...